Company: REVB
Filing Date: 2025-06-09
Form Type: DEF 14A
Source: 0000950170-25-083815
Chunk: 66

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-06-09
Form: DEF 14A
Chunk 66
---
 Plan awards for each named executive officer outstanding as of December 31, 2024:

| Name                       
 James RolkeCEO             |     | Date of Grant 
 2/25/2022(1)  |     | Option-based Awards 
           Number of 
          securities 
          underlying 
         unexercised 
             options 
                 (#) 
                   5 |     | Option   
 exercise 
 price    
 ($)      | 23,520.00 |     | Option     
 expiration 
 date       
 2/25/2032  |     | Stock-based Awards 
 Value of           
 unexercised        
 in-the-money       
 options at         
 December 31,       
 2023               
 ($)                
 —                  |     | Number of   
 shares or   
 units of    
 shares that 
 have not    
 vested      
 (#)         
 —           |     | Market or       
 payout value of 
 share awards    
 that have not   
 vested          
 ($)             
 —               |
|:---------------------------|:----|:--------------|:----|--------------------:|:----|:---------|----------:|:----|:-----------|:----|:-------------------|:----|:------------|:----|:----------------|
| Chester S. Zygmont, IIICFO |     | 2/25/2022(1)  |     |                   1 |     | $        | 23,520.00 |     | 2/25/2032  |     | —                  |     | —           |     | —               |

____________ (1) The stock options vest 25% on the one-year anniversary of the grant date, and thereafter quarterly over a three-year period, subject to continued service through each such vesting date. Pay Versus Performance Disclosure Pay Versus Performance Table As required by Section 953(a) of the Dodd-Frank Act and Item 402(v) of SEC Regulation S-K, we are providing the following information about the relationship between “compensation actually paid” to our “named executive officers,” within the meaning of such rules, and certain financial performance measures of our Company. The table below provides information regarding compensation actually paid to our CEO, who serves as our principal executive officer (“PEO”), and compensation actually paid to our CFO, our only other non-PEO named executive officer, during each of the past two fiscal years, as well as our total stockholder return and net loss for each of the past two fiscal years.

|      | Year |   |